HIV protease inhibitors
US5484926A · kind A · utility
79Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 1994 |
| Grant date | Jan 16, 1996 |
| Priority date | — |
| Expiry date | Feb 2, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/62
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.